Neonatal therapy with PF543, a sphingosine kinase 1 inhibitor, ameliorates hyperoxia-induced airway remodeling in a murine model of bronchopulmonary dysplasia.
American journal of physiology. Lung cellular and molecular physiology 09, 2020 | Pubmed ID: 32697651